A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds can keep taking them in the weeks before a surgery. Concerns had arisen because the drugs, which include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), liraglutide (Saxenda) and dulaglutide (Trulicity), can…  read on >  read on >

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’s disease are climbing sharply, according to research led by Amanda Gusovsky, of…  read on >  read on >

Big surges in new autism diagnoses among young adults, as well a rise in diagnoses for girls and young women, have driven a near-tripling of U.S. autism cases in just over a decade, researchers report. Data on over 12 million patients enrolled in major U.S. health care systems found that between 2011 and 2022 the…  read on >  read on >

A lack of health insurance coverage raises the risk that cancers among Black and Hispanic Americans will be caught too late, a new study suggests. Being uninsured accounts for a significant proportion of racial and ethnic disparities in cancers that are only detected at a later, more life-threatening stage, researchers found. “Securing health insurance for…  read on >  read on >